Valuation: Nipro Corporation

Market Cap 266B 1.67B 1.52B 1.41B 1.27B 2.39B 156B 2.48B 16.98B 6.71B 84.1B 6.26B 6.12B P/E 2027 *
15.1x
P/E 2028 * 11.2x
Enterprise Value 765B 4.8B 4.38B 4.05B 3.65B 6.88B 449B 7.15B 48.89B 19.33B 242B 18.01B 17.63B EV / Sales 2027 *
1.1x
EV / Sales 2028 * 1.03x
Free-Float
85.55%
Yield 2027 *
2.39%
Yield 2028 * 3.3%
1 day+1.73%
1 week+7.62%
Current month+7.70%
1 month+7.35%
3 months-5.90%
6 months-11.33%
Current year-0.61%
1 week 1,356
Extreme 1356
1,479.5
1 month 1,318.5
Extreme 1318.5
1,479.5
Current year 1,292.5
Extreme 1292.5
1,760.5
1 year 1,292.5
Extreme 1292.5
1,760.5
3 years 1,080
Extreme 1080
1,760.5
5 years 987
Extreme 987
1,760.5
10 years 908
Extreme 908
1,760.5
Manager TitleAgeSince
Director of Finance/CFO 58 31/05/2025
President 58 31/05/2025
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 81 25/06/2025
Director/Board Member 54 31/05/2009
Director/Board Member 58 31/05/2009
Change 5-day change 1-year change 3-year change Capi.($)
+1.73%+7.62%-0.84%+33.76% 1.67B
-0.22%-4.40%-19.63%+4.95% 181B
-1.56%-0.88%-0.08%+34.72% 123B
+0.19%-0.20%-11.51%+10.32% 121B
-1.77%-1.28%-42.47%+0.58% 91.11B
-0.64%-0.45%-3.69%+78.62% 66.47B
+0.31%+0.73%+12.35%-7.37% 58.86B
+1.19%-0.59%+4.22%+50.63% 55.03B
+0.38%-2.16%+3.38%+42.16% 48.88B
+0.48%+3.92%+3.54%-0.57% 35.5B
Average +0.16%+0.58%-5.47%+24.78% 78B
Weighted average by Cap. -0.12%-1.10%-9.99%+20.64%

Financials

2027 *2028 *
Net sales 696B 4.37B 3.98B 3.68B 3.32B 6.26B 408B 6.51B 44.49B 17.59B 220B 16.39B 16.05B 726B 4.56B 4.16B 3.84B 3.47B 6.53B 426B 6.79B 46.41B 18.35B 230B 17.1B 16.74B
Net income 15.47B 97.15M 88.6M 81.92M 73.93M 139M 9.08B 145M 989M 391M 4.9B 364M 357M 20.7B 130M 119M 110M 98.89M 186M 12.14B 194M 1.32B 523M 6.55B 488M 477M
Net Debt 499B 3.13B 2.86B 2.64B 2.38B 4.49B 293B 4.67B 31.91B 12.61B 158B 11.76B 11.51B 481B 3.02B 2.75B 2.55B 2.3B 4.33B 282B 4.5B 30.76B 12.16B 152B 11.33B 11.09B
Projected Income Statement - Annual - Nipro Corporation
Logo Nipro Corporation
Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.
Employees
38,593
Date Price Change Volume
19/11/26 JP¥1,468.00 +1.73% 665,500
18/11/26 JP¥1,443.00 -1.74% 691,100
17/11/26 JP¥1,468.50 +3.23% 1,361,500
16/11/26 JP¥1,422.50 +3.49% 798,600
13/11/26 JP¥1,374.50 +0.77% 681,900
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Nipro Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1,443.00JPY
Average target price
1,936.00JPY
Spread / Average Target
+34.16%
  1. Stock Market
  2. Stocks
  3. 8086 Stock